Romosozumab or Alendronate for Fracture Prevention in East Asian Patients: A Subanalysis of the Phase III, Randomized ARCH Study

Osteoporosis International - United Kingdom
doi 10.1007/s00198-020-05324-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Meta-Analysis of Randomized Phase II and Phase III Trials of Gemcitabine With/Without S-1 in Asian Patients With Advanced Pancreatic Cancer.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Romosozumab — Promising or Practice Changing?

New England Journal of Medicine
Medicine
2017English

Phase III Randomized Study of Two Fluorouracil Combinations With Either Interferon Alfa-2a or Leucovorin for Advanced Colorectal Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
1996English

Outcomes in Patients With Aggressive or Refractory Disease From REVEL, a Randomized Phase III Study of Docetaxel With Ramucirumab or Placebo for Second-Line Treatment of Stage IV Non-Small-Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2017English

A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2015English

Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2018English

Prevention of Meteopathy in Patients With Arterial Hypertension: A Pilot Comparative Randomized Study

Boletin Sociedad Española Hidrologia Medica
2018English

Journal Club: Randomized Phase III Study of Whole-Brain Radiotherapy for Primary CNS Lymphoma

Neurology
Neurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy